Date: July 06, 2023 Public Announcement (NASDAQ

Date: July 06, 2023


Public Announcement





Incannex Receives Ethics Approval for...

Related Keywords

Australia ,Adelaide ,South Australia ,Melbourne ,Victoria ,United States ,American ,Australian ,Mark Bleackley ,Joel Latham ,Edison Group ,Incannex Healthcare ,Continuous Positive Airway Pressure ,Incannex Healthcare Limited Nasdaq ,Drug Administration ,Nasdaq ,Australian Stock Exchange ,Bellberry Human Research Ethics Committee ,Incannex Healthcare Limited ,Clinical Research ,Receives Ethics Approval ,Bioavailability Clinical Trial ,Proprietary Drug ,Obstructive Sleep Apnoea ,Healthcare Limited ,Rialto South Tower ,Chief Scientific Officer Dr Mark Bleackley ,Incannex Board ,American Depository Shares ,Securities Litigation Reform Act ,Chief Executive Officer ,Relations Contact ,